Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLumos Pharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.14 | -$1.14 | -$1.14 |
| Q2 2024 | 1 | -$1.17 | -$1.17 | -$1.17 |
| Q3 2024 | 1 | -$0.73 | -$0.73 | -$0.73 |
| Q4 2024 | 1 | -$0.67 | -$0.67 | -$0.67 |
| Q1 2025 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q2 2025 | 1 | -$0.36 | -$0.36 | -$0.36 |
| Q3 2025 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q4 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q1 2026 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q2 2026 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q3 2026 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q4 2026 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q1 2027 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q2 2027 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q3 2027 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q4 2027 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q1 2028 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2028 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q3 2028 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q4 2028 | 1 | -$0.19 | -$0.19 | -$0.19 |
Lumos Pharma, Inc. Earnings Date And Information
Lumos Pharma, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.9 earnings per share for the quarter, missing analysts' consensus estimates of $-0.56 by $0.34. The company had revenue of 726,000 for the quarter and had revenue of 2.05 M for the year. Lumos Pharma, Inc. has generated $-4 earnings per share over the last year ($-4.18 diluted earnings per share) and currently has a price-to-earnings ratio of -1.04. Lumos Pharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based on prior year's report dates.
Lumos Pharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.56 | -$0.90 | -0.34 | $302,500 | $726,000 |
| 08/02/2024 | Q2 2024 | -$0.93 | $265,000 | $488,000 | ||
| 05/15/2024 | Q1 2024 | -$1.29 | $165,000 | |||
| 04/22/2024 | Q4 2023 | -$1.17 | $826,000 | |||
| 11/07/2023 | Q3 2023 | -$1.10 | -$1.04 | 0.06 | $225,400 | $7,000 |
| 08/10/2023 | Q2 2023 | -$1.09 | $365,167 | $527,000 | ||
| 05/05/2023 | Q1 2023 | -$0.81 | $691,000 | |||
| 03/07/2023 | Q4 2022 | -$0.93 | $512,000 | |||
| 11/14/2022 | Q3 2022 | -$1.01 | -$0.86 | 0.15 | $66,667 | $497,000 |
| 08/10/2022 | Q2 2022 | -$0.93 | $18,500 | $403,000 | ||
| 05/11/2022 | Q1 2022 | -$0.92 | $111,000 | |||
| 03/11/2022 | Q4 2021 | -$0.68 | $220,000 | |||
| 11/05/2021 | Q3 2021 | -$0.90 | $0 | |||
| 08/06/2021 | Q2 2021 | -$0.99 | $10,000 | |||
| 05/06/2021 | Q1 2021 | -$1.04 | $0 | |||
| 03/09/2021 | Q4 2020 | -$0.85 | -$0.29 | 0.56 | $40,000 | |
| 11/12/2020 | Q3 2020 | $0.21 | $2.60 M | $74,000 | ||
| 08/14/2020 | Q2 2020 | -$0.65 | $33,000 | |||
| 06/02/2020 | Q1 2020 | $0.16 | $21,000 | |||
| 03/03/2020 | Q4 2019 | -$1.99 | $433,000 |
Lumos Pharma, Inc. Earnings: FAQ's
When is Lumos Pharma, Inc.'s earnings date?
Lumos Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates.
How can I listen to Lumos Pharma, Inc.'s earnings conference
call?
The conference call for Lumos Pharma, Inc.'s latest earnings report can be listened to online.
How can I read Lumos Pharma, Inc.'s conference call transcript?
The conference call transcript for Lumos Pharma, Inc.'s latest earnings report can be read online.
How much revenue does Lumos Pharma, Inc. generate each year?
Lumos Pharma, Inc. (:LUMO) has a recorded annual revenue of $2.05 M.
How much profit does Lumos Pharma, Inc. generate each year?
Lumos Pharma, Inc. (:LUMO) has a recorded net income of $2.05 M. Lumos Pharma, Inc. has generated $-4.18 earnings per share over the last four quarters.
What is Lumos Pharma, Inc.'s price-to-earnings ratio?
Lumos Pharma, Inc. (:LUMO) has a price-to-earnings ratio of -1.04 and price/earnings-to-growth ratio is -0.33.